Novo Nordisk’s Ozempic Recommended by EU for Peripheral Arterial Disease in Type 2 Diabetes

Read more

Datroway Approved in U.S. for Advanced EGFR-Mutated Lung Cancer

Read more

argenx Wins EU Approval for VYVGART SC to Treat CIDP

Read more

Harbour BioMed and Otsuka Partner Globally to Develop BCMAxCD3 Bispecific T-Cell Engagers

Read more

Archeus Technologies Gets FDA Clearance for ART-101 Prostate Cancer Trial

Read more

Health Canada Approves Novartis’ KISQALI for High-Risk Early Breast Cancer

Read more

Advarra Launches AI Council to Boost Innovation in Clinical Trials

Read more

RyboDyn Joins Lilly Gateway Labs to Advance Immunotherapies Targeting Dark Proteome

Read more

Yeztugo Becomes First FDA-Approved HIV Prevention with 6-Month Protection

Read more

Actio Biosciences Raises $66M in Series B to Advance Genetics-Based Therapies

Read more